Teva Pharmaceutical Industries Ltd. has appointed Matthew Shields as Executive Vice President of Teva Global Operations (TGO), the company’s manufacturing and supply division, effective June 3, 2024.
 
Shields succeeds Eric Drapé, who is leaving after 11 years with the Company. Shields will be a member of Teva’s Executive Leadership Team and report directly to President and CEO Richard Francis. He will be based in Teva’s U.S. headquarters in Parsippany, NJ.

About Matthew Shields

Shields joins Teva with over 25 years’ experience in the global biopharmaceutical and animal health industries. As an engineer by trade, Shields brings significant experience at every stage of the manufacturing and supply process.
 
Most recently, he served as Senior Vice President for Animal Health Manufacturing for Merck, known as MSD Animal Health outside of the United States and Canada, where he oversaw end-to-end manufacturing, supply chain, procurement, and process development. Previously, he led Specialty Care Manufacturing, Engineering, and Operational Excellence for Sanofi. Shields spent much of his early career at Amgen, where he held a variety of leadership roles in Operations.
 
Richard Francis, Teva’s President and CEO stated: “I’m thrilled to welcome a transformational leader of Matthew’s caliber to the executive team at Teva. Matthew brings a wealth of experience in health operations that are critical to fulfilling our purpose by enabling Teva to execute on our promises to patients and healthcare systems around the world. Matthew is ideally positioned to lead our TGO organization through the next phase of our Pivot to Growth journey.”
 
 “Teva is clearly a company with incredible potential based on the early progress of its Pivot to Growth strategy, and its tremendous heritage in manufacturing important medicines serving the needs of patients around the world,” Shields remarked. “I’m honored to take on this critical role, and eager to begin working with the talented team in Teva Global Operations, and my colleagues across the Company, to deliver on our inspiring purpose.”